These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
509 related items for PubMed ID: 37274066
1. Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases. Steinhoff H, Acs M, Blaj S, Dank M, Herold M, Herold Z, Herzberg J, Sanchez-Velazquez P, Strate T, Szasz AM, Piso P. World J Gastroenterol; 2023 May 14; 29(18):2850-2863. PubMed ID: 37274066 [Abstract] [Full Text] [Related]
4. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy]. An SL, Ji ZH, Li XB, Liu G, Zhang YB, Gao C, Zhang K, Zhang XJ, Yan GJ, Yan LJ, Li Y. Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May 25; 26(5):434-441. PubMed ID: 37217351 [Abstract] [Full Text] [Related]
5. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy. Zhou S, Jiang Y, Liang J, Pei W, Zhou Z. World J Surg Oncol; 2021 May 17; 19(1):151. PubMed ID: 34001125 [Abstract] [Full Text] [Related]
8. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches. Chang SC, Fingerhut A, Chen WT. Surg Oncol; 2022 Aug 17; 43():101766. PubMed ID: 35430126 [Abstract] [Full Text] [Related]
11. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review. Chow FC, Yip J, Foo DC, Wei R, Choi HK, Ng KK, Lo OS. Asian J Surg; 2021 Jan 17; 44(1):221-228. PubMed ID: 32605790 [Abstract] [Full Text] [Related]
15. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Manzanedo I, Pereira F, Rihuete Caro C, Pérez-Viejo E, Serrano Á, Gutiérrez Calvo A, Regueira FM, Casado-Adam Á, Cascales-Campos PA, Arteaga X, García-Fadrique A, Gómez Sanz R, López García A, Zozaya G, Arjona Á, Gil Martínez J. Ann Surg Oncol; 2019 Aug 17; 26(8):2615-2621. PubMed ID: 31115852 [Abstract] [Full Text] [Related]
17. Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis. Buckarma E, Thiels CA, Jin Z, Grotz TE. Ann Surg Oncol; 2024 Jan 17; 31(1):622-629. PubMed ID: 37880514 [Abstract] [Full Text] [Related]
18. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy vs. cytoreductive surgery alone for intrahepatic cholangiocarcinoma with peritoneal metastases: A retrospective cohort study. Feng F, Gao Q, Wu Y, Liu C, Yu Y, Li B, Chu K, Yi B, Cheng Q, Jiang X. Eur J Surg Oncol; 2021 Sep 17; 47(9):2363-2368. PubMed ID: 34119376 [Abstract] [Full Text] [Related]
19. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study. Yu P, Ye Z, Dai G, Zhang Y, Huang L, Du Y, Cheng X. BMC Cancer; 2020 Nov 16; 20(1):1108. PubMed ID: 33198674 [Abstract] [Full Text] [Related]